In a research report published Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), with a …
Canaccord analyst Camilo Lyon is stepping down from the sidelines on Lululemon Athletica inc. (NASDAQ:LULU) with a new bearish forecast for the athletic …
Let’s talk about F.A.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares stumbled over 10% in the past two days, after the Wall Street Journal reported that the deal making …
Canaccord analyst Camilo Lyon reiterated a Buy rating on shares of Under Armour Inc (NYSE:UA), with a price target of $44, after hosting …
Red flags were thrown up by analysts today regarding the prospects of Stratasys, Ltd. (NASDAQ:SSYS), after the 3D printing giant reported disappointing results for the …
Canaccord analyst John Newman speculates on Palatin Technologies, Inc. (NYSEMKT:PTN) ahead of clinical data and partnership updates with a bullish forecast, reiterating a …
Canaccord analyst Matt Ramsay recently hosted investor meetings in New York and Boston last week with Forrest Norrod, senior vice president and general …
AEterna Zentaris (NASDAQ:AEZS) delivered a financial third-quarter report on Tuesday, November 8th that “modestly” underperformed Canaccord analyst Neil Maruoka‘s expectations “on a lighter …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) posted a third-quarter print yesterday that was decent in terms of revenue, but found itself missing when it …
